AAV Packaging Services Market

FMI analysis indicates that the future of the AAV packaging services market will be shaped by specialized CDMO platforms that operate as pure-play gene therapy manufacturing partners rather than ancillary service providers. As adeno-associated virus programs advance from experimental research into late-stage clinical and commercial development, demand will revolve around providers capable of delivering integrated GMP-compliant packaging.